Categories: Tech

Constellation Software Inc. Announces Release Date for Third Quarter Results

 | Source: Constellation Software Inc.

TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced today it intends to release its third quarter results on November 7, 2025.

The Company’s quarterly results will be disseminated via press release and made available on the Company’s website (www.csisoftware.com) and the SEDAR website (www.sedarplus.ca), after markets close on Friday, November 7, 2025. As outlined in Constellation’s press release on February 23, 2018, Constellation has ceased holding conference calls to discuss the Company’s quarterly financial results. In lieu of the quarterly calls the Company has created a link on its website where shareholders can submit questions to management. Periodically the Company will publish responses to selected questions received. The Company believes this Q&A facility will eventually prove to be a more effective tool than the conference calls because it will be searchable and will provide an archive of all previous responses.

The Company’s goal in establishing this policy is to allow all investors ongoing access to information disclosed about Constellation’s strategy, operations, and ongoing business plans.

Website link: https://www.csisoftware.com/investor-relations/shareholder-q-and-a

About Constellation Software Inc.
Constellation Software acquires, manages and builds vertical market software businesses.

Contact:

Jamal Baksh
Chief Financial Officer
416-861-9677

GlobeNews Wire

Recent Posts

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

2 weeks ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

3 weeks ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

3 weeks ago

Secret Ingredient’s 2025: Redefining Hospitality through Story, Space and Strategy

NEW DELHI, Dec. 31, 2025 /PRNewswire/ -- Secret Ingredient, one of India's foremost food and…

1 month ago

GAC Receives Industry’s First Vehicle Data Security Management System Certificate

TIANJIN, China and GUANGZHOU, China, Dec. 31, 2025 /PRNewswire/ -- On December 24th, GAC received…

1 month ago